Preventing Off-weight Tablets - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Preventing Off-weight Tablets
Operator training, preventive maintenance, and regularly scheduled calibration help prevent the manufacture of off-weight tablets.

Equipment and Processing Report

Weight is a crucial parameter of any finished drug tablet, whether prescription, over-the-counter, or nutritional supplement. Overweight tablets can result in too much of an ingredient, which may lead to a harmful effect. But tablets that are too light are also problematic because they may not offer enough of a particular ingredient to bring about an intended therapeutic benefit.  A manufacturer’s goal should be two-fold: do not produce off-weight tablets in the first place, and catch and reject them, accurately and reliably, if they are produced. The best ways to prevent the manufacturing of off-weight tablets begin before product is loaded into the hopper—through comprehensive operator training, diligent and rigorous preventive maintenance, and regularly scheduled calibration of the press and its subassemblies.

Operator training
The best and first line of defense is training on both press and process. Operators should be tested regularly to ascertain and reconfirm their proficiency with making a tablet in the absence of automation (i.e., “Tableting 101”) and with making tablets using the specific equipment their company employs as part of the manufacturing process. Training should cover the prevention of virtually all the potential causes of off-weight tablets, including how to avoid the following common causes:

  • Incorrect or suboptimal weight-related machine settings, such as filling depth
  • Poor or inconsistent filling of dies
  • Improperly set (or missing) recirculation components
  • Tablet back-up at the take-off, where rogue tablets may jump the bar and potentially re-enter a feeder
  • No rejection of start-up material or improper settings related to start-up
  • Suboptimal punch penetration settings
  • Improper manipulation of a feeder by the operator or a poor understanding of how a feeder configuration can be modified to better suit a particular product’s flow characteristics.

The importance of training cannot be overstated.  Companies should have standard operating procedures (SOPs) and ensure that operators follow the SOPs. A tablet-press vendor should be able to demonstrate and confer comprehensive knowledge of their technology and of how it can be used to manufacture tablets of optimal quality.

A press vendor can provide training specific to understanding the feeder and optimizing its use, because the feeder has a direct correlation to maintaining acceptable tablet weights. Users should also understand and use the relationship between feeder speeds and consistent die filling.

Maintenance and calibration
Thorough preventive maintenance and regular inspection and calibration should be conducted on the entire tablet press.  In particular, users should maintain calibration of devices controlling filling depth regulation on a press.  Tooling and cams should be consistently and carefully inspected. Cam-wear indicators should be used whenever possible. A guideline for what constitutes a worn tool should be established, and it should serve as a prompt for timely replacement.

A force-based relative standard deviation should be used as an indicator of consistent tablet weights. Given the correlation between force and final tablet weight, this statistic allows an operator, with a quick glance, to determine how consistently they are compressing tablets. Many modern presses calculate this figure for the user, further streamlining the ability to quickly analyze results in real time.

Seek outside help
Companies should solicit the help of third-party experts such as tablet-press vendors, reputable consultants, or specialists in overall equipment effectiveness. Such assessments can immediately uncover multiple inadequacies in the process, machine, and/or user. The engagement of these individuals or organizations is especially valuable because they generally view the situation through a different lens, rather than being focused on getting product out the door. Off-weight tablets warrant serious attention, but through collaborative efforts this problem should be reversible and avoidable.

Matt Bundenthal is direct sales and communications manager at Fette Compacting America.

For further information on this topic, read the January 2014 issue of Pharmaceutical Technology for the full article, “Battling Off-Weight Tablets.”


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Equipment and Processing Report,
Click here